| Entry |
|
|---|
| Name |
Muromonab-CD3 (JAN/USAN/INN);
Orthoclone okt3 (TN) |
|---|
| Remark |
|
|---|
| Efficacy |
Immunosuppressant |
|---|
| Type |
Monoclonal antibody |
|---|
| Target |
|
|---|
| Pathway |
| hsa04658 | Th1 and Th2 cell differentiation |
| hsa04660 | T cell receptor signaling pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AG Monoclonal antibodies
L04AG01 Muromonab-CD3
D05092 Muromonab-CD3 (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Other cell surface molecules
CD molecules
CD3
D05092 Muromonab-CD3 (JAN/USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
